Fundies. English
Segment disclosures
Company overviewPDL BIOPHARMA, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
40 dimension combinations 278 retained observations 21 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Medicaldevices · Other
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=pdli:MedicaldevicesMember;us-gaap:StatementBusinessSegmentsAxis=pdli:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 433000 | USD | 20200311 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 377000 | USD | 20200311 | Open filing evidence |
Medicaldevices · Asia
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=pdli:MedicaldevicesMember;us-gaap:StatementBusinessSegmentsAxis=srt:AsiaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 11536000 | USD | 20200311 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 7136000 | USD | 20200311 | Open filing evidence |
Medicaldevices · Europe
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=pdli:MedicaldevicesMember;us-gaap:StatementBusinessSegmentsAxis=srt:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 3438000 | USD | 20200311 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 2451000 | USD | 20200311 | Open filing evidence |
Medicaldevices · North America
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=pdli:MedicaldevicesMember;us-gaap:StatementBusinessSegmentsAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 10155000 | USD | 20200311 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 7425000 | USD | 20200311 | Open filing evidence |
Other · Medicaldevices
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=pdli:OtherMember;us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-08-31 | 200000 | USD | 20210329 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 433000 | USD | 20210329 | Open filing evidence |
Pharmaceutical · Other
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=pdli:PharmaceuticalMember;us-gaap:StatementBusinessSegmentsAxis=pdli:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 0 | USD | 20200311 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 0 | USD | 20200311 | Open filing evidence |
Pharmaceutical · Asia
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=pdli:PharmaceuticalMember;us-gaap:StatementBusinessSegmentsAxis=srt:AsiaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 6243000 | USD | 20200311 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 13637000 | USD | 20200311 | Open filing evidence |
Pharmaceutical · Europe
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=pdli:PharmaceuticalMember;us-gaap:StatementBusinessSegmentsAxis=srt:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 22816000 | USD | 20200311 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 25259000 | USD | 20200311 | Open filing evidence |
Pharmaceutical · North America
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=pdli:PharmaceuticalMember;us-gaap:StatementBusinessSegmentsAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 26034000 | USD | 20200311 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 41900000 | USD | 20200311 | Open filing evidence |
Asia · Medicaldevices
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AsiaMember;us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-03-31 | 2269000 | USD | 20200511 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 2158000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 4915000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 1643000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 2757000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 1114000 | USD | 20190509 | Open filing evidence |
Asia · Pharmaceutical
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AsiaMember;us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | -135000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 4951000 | USD | 20200810 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1923000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 4163000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 2241000 | USD | 20200511 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 1926000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 12078000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 8732000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 10152000 | USD | 20190807 | Open filing evidence |
Europe · Medicaldevices
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-08-31 | 2078000 | USD | 20210329 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 3438000 | USD | 20210329 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 1017000 | USD | 20200511 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 565000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 1859000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 679000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 1294000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 615000 | USD | 20190509 | Open filing evidence |
Europe · Pharmaceutical
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-08-31 | 13008000 | USD | 20210329 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 22816000 | USD | 20210329 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 5582000 | USD | 20200511 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 5810000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 18172000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 6371000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 12362000 | USD | 20190807 | Open filing evidence |
North America · Medicaldevices
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-03-31 | 2084000 | USD | 20200511 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 2315000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 4634000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 615000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 2319000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 1704000 | USD | 20190509 | Open filing evidence |
North America · Pharmaceutical
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-03-31 | 12138000 | USD | 20200511 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 10036000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 31743000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 10776000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 21707000 | USD | 20190807 | Open filing evidence |
Non Us · Medicaldevices
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:NonUsMember;us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-03-31 | 119000 | USD | 20200511 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 65000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 285000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 107000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 220000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 113000 | USD | 20190509 | Open filing evidence |
Non Us · Pharmaceutical
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:NonUsMember;us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-03-31 | 0 | USD | 20200511 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 0 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 0 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 0 | USD | 20190807 | Open filing evidence |
Incomegeneratingassets
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:IncomegeneratingassetsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 37000 | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 110000 | USD | 20210329 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 63000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 73000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 10000 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | -36000 Restated | USD | 20210329 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | -45000 Restated | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | -39000 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 36000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 6000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | -30000 Restated | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 92662000 | USD | 20200311 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 43511000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 73519000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 14814000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 30008000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 15194000 | USD | 20190509 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 235937000 | USD | 20190315 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 42682000 | USD | 20181107 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 200547000 | USD | 20181107 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 125006000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 157864000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 32859000 | USD | 20180509 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 212632000 | USD | 20180316 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 39510000 | USD | 20171113 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 163681000 | USD | 20171113 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 21047000 | USD | 20170803 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 124171000 | USD | 20170803 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 103124000 | USD | 20170503 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 590448000 | USD | 20170301 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 124618000 | USD | 20161103 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 412390000 | USD | 20161103 | Open filing evidence |
Medicaldevices
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 4078000 Restated | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 15211000 Restated | USD | 20210329 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 5148000 Restated | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 11133000 Restated | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 5985000 Restated | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 30742000 Restated | USD | 20210329 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 8076000 Restated | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 22224000 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 7422000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 14148000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 6726000 Restated | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 24652000 Restated | USD | 20200311 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 6615000 Restated | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 17479000 Restated | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 5882000 Restated | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 10864000 Restated | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 4982000 Restated | USD | 20190509 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 15091000 | USD | 20190315 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 4963000 | USD | 20181107 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 7580000 | USD | 20181107 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 2617000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 2617000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 0 | USD | 20180509 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 0 | USD | 20180316 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 0 | USD | 20171113 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 0 | USD | 20171113 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 0 | USD | 20170803 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 0 | USD | 20170803 | Open filing evidence |
Medicaldevices · Asia
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember;srt:StatementGeographicalAxis=srt:AsiaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 618000 | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 4137000 | USD | 20210329 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 2399000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 3519000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 11536000 | USD | 20210329 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 3178000 | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 8540000 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 3093000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 5362000 | USD | 20200810 | Open filing evidence |
Medicaldevices · Europe
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember;srt:StatementGeographicalAxis=srt:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 522000 | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 2078000 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 633000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1556000 | USD | 20200810 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 699000 | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 2421000 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 705000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 1722000 | USD | 20200810 | Open filing evidence |
Medicaldevices · North America
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 2172000 | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 6656000 | USD | 20210329 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1757000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 4484000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 10155000 | USD | 20210329 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 2779000 | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 7066000 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2203000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 4287000 | USD | 20200810 | Open filing evidence |
Medicaldevices · Non Us
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember;srt:StatementGeographicalAxis=us-gaap:NonUsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 63000 | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 200000 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 137000 | USD | 20200810 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 68000 | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 253000 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 66000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 185000 | USD | 20200810 | Open filing evidence |
Medicaldevices · Asia
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember;us-gaap:StatementGeographicalAxis=us-gaap:AsiaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 1643000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 2757000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 1114000 | USD | 20180509 | Open filing evidence |
Medicaldevices · Europe
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember;us-gaap:StatementGeographicalAxis=us-gaap:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 679000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 1294000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 615000 | USD | 20180509 | Open filing evidence |
Medicaldevices · Non Us
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember;us-gaap:StatementGeographicalAxis=us-gaap:NonUsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 107000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 220000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 113000 | USD | 20180509 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 0 | USD | 20180809 | Open filing evidence |
Medicaldevices · North America
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:MedicaldevicesMember;us-gaap:StatementGeographicalAxis=us-gaap:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 615000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 2319000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 1704000 | USD | 20180509 | Open filing evidence |
Pharmaceutical
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 0 Restated | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 0 Restated | USD | 20210329 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 0 Restated | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 Restated | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 Restated | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 0 Restated | USD | 20210329 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 Restated | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 0 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 0 Restated | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 80796000 | USD | 20200311 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 17772000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 61993000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 25879000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 44221000 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 18342000 | USD | 20190509 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 69032000 | USD | 20190315 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 15104000 | USD | 20181107 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 43897000 | USD | 20181107 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 16212000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 28794000 | USD | 20180809 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 12581000 | USD | 20180509 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 31669000 | USD | 20180316 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 14128000 | USD | 20171113 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 14128000 | USD | 20171113 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 0 | USD | 20170803 | Open filing evidence |
| 2016-01-01 – 2016-06-30 | 0 | USD | 20170803 | Open filing evidence |
Pharmaceutical · Other
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember;srt:StatementGeographicalAxis=pdli:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-08-31 | 0 | USD | 20210329 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 0 | USD | 20210329 | Open filing evidence |
Pharmaceutical · Asia
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember;srt:StatementGeographicalAxis=srt:AsiaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 1428000 | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 6378000 | USD | 20210329 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 6243000 | USD | 20210329 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 654000 | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 4817000 | USD | 20201113 | Open filing evidence |
Pharmaceutical · Europe
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember;srt:StatementGeographicalAxis=srt:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 3144000 | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 13008000 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 4104000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 9863000 | USD | 20200810 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 5496000 | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 16532000 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 5454000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 11036000 | USD | 20200810 | Open filing evidence |
Pharmaceutical · North America
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 1709000 | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 10093000 | USD | 20210329 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 4198000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 8384000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 26034000 | USD | 20210329 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 6119000 | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 21295000 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 3038000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 15176000 | USD | 20200810 | Open filing evidence |
Pharmaceutical · Non Us
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember;srt:StatementGeographicalAxis=us-gaap:NonUsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 0 | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 0 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 | USD | 20200810 | Open filing evidence |
Pharmaceutical · Asia
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember;us-gaap:StatementGeographicalAxis=us-gaap:AsiaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 8732000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 1420000 | USD | 20180509 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 10152000 | USD | 20180809 | Open filing evidence |
Pharmaceutical · Europe
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember;us-gaap:StatementGeographicalAxis=us-gaap:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 6371000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 5991000 | USD | 20180509 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 12362000 | USD | 20180809 | Open filing evidence |
Pharmaceutical · Non Us
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember;us-gaap:StatementGeographicalAxis=us-gaap:NonUsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 0 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 0 | USD | 20180509 | Open filing evidence |
Pharmaceutical · North America
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:PharmaceuticalMember;us-gaap:StatementGeographicalAxis=us-gaap:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 10776000 | USD | 20180809 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 10931000 | USD | 20180509 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 21707000 | USD | 20180809 | Open filing evidence |
Productsales
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:ProductsalesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-01-01 – 2017-03-31 | 12581000 | USD | 20170503 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 31669000 | USD | 20170301 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 14128000 | USD | 20161103 | Open filing evidence |
| 2016-01-01 – 2016-09-30 | 14128000 | USD | 20161103 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 0 | USD | 20170503 | Open filing evidence |
| 2015-01-01 – 2015-12-31 | 0 | USD | 20170301 | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 0 | USD | 20161103 | Open filing evidence |
| 2015-01-01 – 2015-09-30 | 0 | USD | 20161103 | Open filing evidence |
Strategicpositions
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pdli:StrategicpositionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 0 | USD | 20201113 | Open filing evidence |
| 2020-01-01 – 2020-08-31 | 0 | USD | 20210329 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 0 | USD | 20210329 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 | USD | 20201113 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 0 | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 0 | USD | 20200311 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 0 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 0 | USD | 20190807 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 0 | USD | 20190807 | Open filing evidence |
Operating Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-08-31 | 4115000 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 5211000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 5995000 | USD | 20200511 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 8031000 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 7458000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 6696000 | USD | 20200511 | Open filing evidence |